- Home»
- The Billing Beat Newsletter»
- MolDX: Cystatin C Measurement Final LCD – Effective February 11, 2019
MolDX: Cystatin C Measurement Final LCD – Effective February 11, 2019
January 8, 2019Medicare Coverage Database (MCD) Number/Contractor Determination Number: L37618
LCD Title: MolDX: Cystatin C Measurement
Effective Date: February 11, 2019
Summary of LCD: Cystatin C is a low molecular weight protein produced by all nucleated cells in the body at a constant rate. It has been proposed and investigated as an improved marker of renal function and as a potential alternative to serum creatinine based estimated glomerular filtration rate (eGFR), as well as a biomarker for predicting cardiovascular risk.